Dr. Michel S. Makaroun, a professor of surgery and of clinical and translational science at the University of Pittsburgh, was elected vice president of the Society for Vascular Surgery (SVS) at the Society’s 2016 Vascular Annual Meeting in June.
[[{"type":"media","view_mode":"media_large","fid":"840","attributes":{"alt":"","class":"media-image","height":"480","style":"width: 177px; height: 198px; float: left; margin-left: 8px; margin-right: 8px;","typeof":"foaf:Image","width":"430"}}]]CHICAGO, Ill., July 11, 2016 — Vascular surgeon
CHICAGO, Ill., July 11, 2016 — As he completed his term as president of the Society for Vascular Surgery (SVS), Dr. Bruce A. Perler began his term as chair of the SVS Foundation at the society’s 2016 Vascular Annual Meeting near Washington, D.C. in June.
R. Clement Darling III, MD, was elected president-elect of the Society for Vascular Surgery (SVS) at the 2016 Vascular Annual Meeting in June.
A new reporting standards document on Endovascular Treatment of Chronic Lower Extremity Peripheral Arterial Disease (PAD) has been posted on the website of the July 2016 issue of the Journal of Vascular Surgery. Lead authors are Drs. Mike Stoner and Keith Calligaro.
The variety of endovascular devices and techniques to treat occlusive disease has exploded over the past 10 years and critical evaluation of the reported results may be problematic. The Society for Vascular Surgery has released new reporting standards focused on endovascular treatment of chronic lower extremity peripheral artery disease. Recommended reporting standards for lower extremity ischemia were last published by the SVS in 1997.
The unique relationship that vascular surgeons enjoy with their patients has enabled our specialty to have a special claim on the way we care for patients. Outgoing SVS President Bruce Perler spoke during the 2016 Vascular Annual Meeting near Washington, D.C. on June 10.
A groundbreaking trial needs more patients enrolled – quickly – and the SVS is asking for your help.
CHICAGO, Illinois - Conventional wisdom might suppose that everyone would avoid surgery if possible.
CHICAGO, Illinois, May 6, 2016 –The Society for Vascular Surgery Board of Directors is pleased to announce Kenneth M. Slaw, Ph.D., as the society’s next executive director, replacing Rebecca Maron, CAE, who will retire May 30, 2016.
Chicago, Illinois– Could microbes in the gut impact human arteries? Surprising early research suggests they might play a role.
The Society for Vascular Surgery and the SVS Foundation present a number of awards during the Vascular Annual Meeting. The achievements and special efforts of many also receive special recognition.
While the 2016 Vascular Annual Meeting includes postgraduate courses, hands-on workshops and other courses, it also features special lectures and forums that add to attendees' overall understanding of the treatment of vascular diseases. Special VAM events include:
CHICAGO, Illinois - Previous studies have shown that women are more likely than men to die after vascular surgery, but a new study shows that they are far more likely to be readmitted to the hospital after aortic aneurysm surgery as well.
A letter to members from SVS President Dr. Bruce A. Perler and SVS PAC Steering Committee Chair Dr. Randall DeMartino:
A recent review of patients who had undergone carotid, lower extremity bypass, or abdominal aortic aneurysm surgeries found that patients who received both statins and antiplatelet medications were far more likely to be alive five years later. Patients placed on both an antiplatelet agent and cholesterol medication had an adjusted 40 percent reduced risk of death at five years compared to those who received neither drug. Being on either one of these medications was also important, and was associated with an adjusted 30 percent reduced risk of death compared to those on neither medication. When considered differently, an extra 14 of every 100 patients were alive at five years if on both medications.
CHICAGO, Illinois - Society for Vascular Surgery Executive Director Rebecca Maron has announced her retirement, effective the end of May. She has served in that position for 13 years.
All too often patients say they are "blindsided" by unexpected outcomes of surgery. SVS member Dr. Margaret "Gretchen" Schwarze has won a prestigious PCORI grant to study ways to help patients understand what major surgery will mean to them.
A three-year study, which gives patients a better way to talk to their surgeon, has earned a $2.1 million grant from the Patient-Centered Outcomes Research Initiative (PCORI).
The Chicago-based Society for Vascular Surgery has announced it will relocate its headquarters to Rosemont, Ill., near Chicago’s O’Hare International Airport, as of March 1, 2019. The SVS is an international, not-for-profit professional medical society, serving specialty-trained vascular surgeons and allied professionals.
Dear Friends: I hope that you had a great Thanksgiving and that you also had an opportunity to review our recent message about making a year-end contribution to the SVS Foundation.
If you haven’t already donated, #GivingTuesday would be the ideal time to do so.
Dr. Norman Rich decided his career path early in life, listening to the doctor who delivered him relay the horrors of the amputations of World War I. “‘Someday, blood vessels will be repaired,’ he told me,” said Dr. Rich of his early mentor, Dr. Otto Utzinger of Ray, Ariz.
The dynamic environment in which vascular surgeons are currently practicing has created abundant opportunities for physicians to move into administrative leadership positions across the spectrum of healthcare. An advanced business degree teaches a surgeon the “language” of health care business.
The SVS Foundation is releasing its second new patient information flier – on diabetes and vascular disease – just in time for National Diabetes Month in November.
The turkey has been reduced to sandwiches and a wishbone and the mashed potatoes are just a memory. And between the frenzy of Black Friday and Cyber Monday shopping promotions, you’ve put a dent in your holiday shopping.
Are you an active member or Distinguished Fellow? Let everyone know The SVS Executive Board has announced that all SVS Active Members in good standing will now be considered Fellows of the Society of Vascular Surgery™ (FSVS™).
The Society for Vascular Surgery is creating a private online community, SVSConnect, with a number of resources for SVS members and their peers.
Researchers from Johns Hopkins University have found that obese patients were more likely to have longer procedures and to lose more blood than those who were not obese, and obese patients were more likely to have post-operative problems such as renal failure or wound infections.
The EHR and our troubled health care system, Part 1
BY MALACHI G. SHEAHAN III, MD MEDICAL EDITOR, VASCULAR SPECIALIST
Before the end of the year, members will be able to connect in a big -- new -- way: our online community. To emphasize this linking together, we've named this new community SVSConnect.
INSULIN-DEPENDENT PATIENTS MAY HAVE WORSE VASCULAR SURGICAL OUTCOMES
Recent advances in statins and other medications have led some researchers to suggest that surgical treatments for carotid stenosis should be limited to symptomatic patients – primarily those who have already had a stroke or TIA. However, a new study published in the Journal of Vascular Surgery questions whether medical therapy is a sufficient stroke-reduction strategy. In the study, only 35 percent of stroke patients were receiving both statin and antiplatelet agents prior to their event, suggesting that asymptomatic carotid disease is unrecognized in many individuals, noted lead researcher Dr. W. Darrin Clouse of Massachusetts General Hospital. “And the first manifestation of their disease,” he wrote, “could be the occurrence of a stroke.”
The Chicago-based Society for Vascular Surgery has announced it will relocate its headquarters to Rosemont, Ill., near Chicago’s O’Hare International Airport, as of March 1, 2019. The SVS is an international, not-for-profit professional medical society, serving specialty-trained vascular surgeons and allied professionals.
Dear Friends: I hope that you had a great Thanksgiving and that you also had an opportunity to review our recent message about making a year-end contribution to the SVS Foundation.
If you haven’t already donated, #GivingTuesday would be the ideal time to do so.
Dr. Norman Rich decided his career path early in life, listening to the doctor who delivered him relay the horrors of the amputations of World War I. “‘Someday, blood vessels will be repaired,’ he told me,” said Dr. Rich of his early mentor, Dr. Otto Utzinger of Ray, Ariz.
The dynamic environment in which vascular surgeons are currently practicing has created abundant opportunities for physicians to move into administrative leadership positions across the spectrum of healthcare. An advanced business degree teaches a surgeon the “language” of health care business.
The SVS Foundation is releasing its second new patient information flier – on diabetes and vascular disease – just in time for National Diabetes Month in November.
The turkey has been reduced to sandwiches and a wishbone and the mashed potatoes are just a memory. And between the frenzy of Black Friday and Cyber Monday shopping promotions, you’ve put a dent in your holiday shopping.
Are you an active member or Distinguished Fellow? Let everyone know The SVS Executive Board has announced that all SVS Active Members in good standing will now be considered Fellows of the Society of Vascular Surgery™ (FSVS™).
The Society for Vascular Surgery is creating a private online community, SVSConnect, with a number of resources for SVS members and their peers.
Researchers from Johns Hopkins University have found that obese patients were more likely to have longer procedures and to lose more blood than those who were not obese, and obese patients were more likely to have post-operative problems such as renal failure or wound infections.
The EHR and our troubled health care system, Part 1
BY MALACHI G. SHEAHAN III, MD MEDICAL EDITOR, VASCULAR SPECIALIST
Before the end of the year, members will be able to connect in a big -- new -- way: our online community. To emphasize this linking together, we've named this new community SVSConnect.
INSULIN-DEPENDENT PATIENTS MAY HAVE WORSE VASCULAR SURGICAL OUTCOMES
Recent advances in statins and other medications have led some researchers to suggest that surgical treatments for carotid stenosis should be limited to symptomatic patients – primarily those who have already had a stroke or TIA. However, a new study published in the Journal of Vascular Surgery questions whether medical therapy is a sufficient stroke-reduction strategy. In the study, only 35 percent of stroke patients were receiving both statin and antiplatelet agents prior to their event, suggesting that asymptomatic carotid disease is unrecognized in many individuals, noted lead researcher Dr. W. Darrin Clouse of Massachusetts General Hospital. “And the first manifestation of their disease,” he wrote, “could be the occurrence of a stroke.”